Ireland vs Türkiye: Expenditure on sickness and health care function by type of benefit
Ireland
27,029 Million euro
in 2023
Türkiye
42,975 Million euro
in 2024
Ireland rank
17th
Türkiye rank
15th
Expenditure on sickness and health care function by type of benefit over time
- Ireland
- Türkiye
How they compare
Türkiye currently reports 42,975 Million euro against 27,029 Million euro in Ireland, a difference of 15,946 Million euro.
That makes Türkiye's figure about 1.6 times Ireland's.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Türkiye ahead.
Ireland ranks 17th and Türkiye ranks 15th of 45 countries.
Türkiye has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9,991 Million euro | 14,234 Million euro | 4,243 Million euro | Türkiye |
| 2010s | 15,427 Million euro | 25,118 Million euro | 9,691 Million euro | Türkiye |
| 2020s | 24,483 Million euro | 24,916 Million euro | 433.58 Million euro | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expenditure on sickness and health care function by type of benefit, Ireland or Türkiye?
- Türkiye, at 42,975 Million euro against 27,029 Million euro in Ireland as of 2024.
- What is the difference in expenditure on sickness and health care function by type of benefit between Ireland and Türkiye?
- 15,946 Million euro, with Türkiye ahead.
- How many years of comparable data are there for Ireland and Türkiye?
- 24 years are reported by both, from 2000 to 2023.
- How do Ireland and Türkiye rank globally for expenditure on sickness and health care function by type of benefit?
- Ireland ranks 17th and Türkiye ranks 15th of 45 countries.
- Where does this data come from?
- Eurostat, published as Expenditure on sickness and health care function by type of benefit and means-testing. Statizoid refreshes it automatically from the source and publishes the full history for both places.